Kinase inhibitor library screening identifies synergistic drug combinations effective in sensitive and resistant melanoma cells
Abstract Background Melanoma is the most aggressive and deadly form of skin cancer with increasing case numbers worldwide. The development of inhibitors targeting mutated BRAF (found in around 60% of melanoma patients) has markedly improved overall survival of patients with late-stage tumors, even m...
Main Authors: | Christiane Margue, Demetra Philippidou, Ines Kozar, Giulia Cesi, Paul Felten, Dagmar Kulms, Elisabeth Letellier, Claude Haan, Stephanie Kreis |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-02-01
|
Series: | Journal of Experimental & Clinical Cancer Research |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13046-019-1038-x |
Similar Items
-
A new ALK isoform transported by extracellular vesicles confers drug resistance to melanoma cells
by: Giulia Cesi, et al.
Published: (2018-10-01) -
Cross-Linking Ligation and Sequencing of Hybrids (qCLASH) Reveals an Unpredicted miRNA Targetome in Melanoma Cells
by: Ines Kozar, et al.
Published: (2021-03-01) -
Hypoxia-Induced Adaptations of miRNomes and Proteomes in Melanoma Cells and Their Secreted Extracellular Vesicles
by: Geoffroy Walbrecq, et al.
Published: (2020-03-01) -
Recombinant interleukin-24 lacks apoptosis-inducing properties in melanoma cells.
by: Stephanie Kreis, et al.
Published: (2007-01-01) -
ROS production induced by BRAF inhibitor treatment rewires metabolic processes affecting cell growth of melanoma cells
by: Giulia Cesi, et al.
Published: (2017-06-01)